ImageneBio (IMA) Form 3: Director Stephen Wang reports no shares

ImageneBio, Inc. filed an Initial Statement of Beneficial Ownership (Form 3) for director Stephen Hui Wang relating to an event on 07/25/2025.

Rhea-AI Filing Summary

ImageneBio, Inc. filed an Initial Statement of Beneficial Ownership (Form 3) for director Stephen Hui Wang relating to an event on 07/25/2025. The filing states that no securities are beneficially owned by the reporting person. The Form 3 was executed via Power of Attorney and signed by Erin Butler, Attorney-in-Fact on 10/10/2025. The filing notes it was submitted late due to delays obtaining the reporting person’s EDGAR codes.

Insights

Corporate Governance Analyst

Form 3 shows a director with no reported ownership and a delayed filing.

The Form 3 documents that Stephen Hui Wang is a director and did not beneficially own any company securities as of the reported event date 07/25/2025. This is a simple disclosure of status rather than a transaction.

Timing is a governance consideration: the filing was noted as late because of EDGAR code delays and was signed on 10/10/2025. Investors may monitor subsequent Section 16 filings for any future acquisitions or dispositions that would change ownership status within the standard reporting windows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 3 filed for ImageneBio (IMA) disclose?

The Form 3 discloses that director Stephen Hui Wang reported no securities beneficially owned as of the event date 07/25/2025.

When was the Form 3 for IMA executed and signed?

The Form 3 notes the event date 07/25/2025 and was signed by Erin Butler, Attorney-in-Fact on 10/10/2025.

Why was the Form 3 filed late?

The filing states it was late because of delays in obtaining the reporting person's EDGAR codes.

Does the Form 3 report any derivative or non-derivative holdings?

No. The filing explicitly states no securities are beneficially owned, and no derivative or non-derivative holdings are listed.

Who is the reporting person on this Form 3 for IMA?

The reporting person is Stephen Hui Wang, listed as a Director of ImageneBio, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/10/2025 - 04:34 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Stephen Hui

(Last) (First) (Middle)

C/O IMAGENEBIO, INC.

12526 HIGH BLUFF DRIVE, SUITE 345

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/25/2025

3. Issuer Name and Ticker or Trading Symbol
ImageneBio, Inc. [ IMA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney. This Form 3 is being filed late due to delays in obtaining the reporting person's EDGAR codes.

No securities are beneficially owned.

	/s/ Erin Butler, Attorney-in-Fact	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.